遠東發展(00035.HK)擬發行2.35億美元票據
格隆匯1月18日丨遠東發展(00035.HK)公吿,於2021年1月18日,發行人FEC Finance Limited(公司全資附屬公司)及公司(作為擔保人)與聯席牽頭經辦人訂立認購協議,據此,發行人同意發行而各聯席牽頭經辦人個別同意按總面值2.35億美元的價格認購或促使認購人認購及支付票據。票據將根據有擔保中期票據計劃項下的提取提呈發售及發行,並預期於2021年1月21日或前後發行。
票據發行估計所得款項淨額經扣除佣金及行政支出後將約為2.34億美元,發行人擬將票據發行所得款項淨額用於集團的再融資、業務發展及一般公司用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.